Tachmazidou, Ioanna
,
Hatzikotoulas, Konstantinos http://orcid.org/0000-0002-4699-3672
Southam, Lorraine http://orcid.org/0000-0002-7546-9650
Esparza-Gordillo, Jorge
Haberland, Valeriia
Zheng, Jie
Johnson, Toby
Koprulu, Mine
Zengini, Eleni
Steinberg, Julia
Wilkinson, Jeremy M. http://orcid.org/0000-0001-5577-3674
Bhatnagar, Sahir http://orcid.org/0000-0001-8956-2509
Hoffman, Joshua D.
Buchan, Natalie
Süveges, Dániel
Yerges-Armstrong, Laura
Smith, George Davey http://orcid.org/0000-0002-1407-8314
Gaunt, Tom R. http://orcid.org/0000-0003-0924-3247
Scott, Robert A.
McCarthy, Linda C.
Zeggini, Eleftheria http://orcid.org/0000-0003-4238-659X
Article History
Received: 9 May 2018
Accepted: 4 December 2018
First Online: 21 January 2019
Competing interests
: I.T., J.E.G., T.J., L.Y.A., J.D.H., N.B., R.S., and L.M.C. are employees of GlaxoSmithKline and may own company stock. T.R.G. receives research funding from GlaxoSmithKline and Biogen. V.H. is funded by a research grant from GlaxoSmithKline.